Hi, my name is Pavas Mehra and we are present at
Pareto Securites' 10th annual health care conference in Stockholm
and with me today I have Emil Billbäck, CEO of Bonesupport
Welcome Emil. Thank you so much.
Could you please give us the elevator pitch
Tell us a bit more about Bonesupport and what you are working with.
Well absolutely, Bonesupport is a medical device company
With a unique technology to heal bone injuries
Normally your skeleton, your bones
heal by themselves after an injury
but there are numerous situation where this doesn't work
and there you need to help nature to progress
and that is where you have our product
Okay, and how does that work practically
How is the process.
When healing the patients
I think you could say that our product
CERAMENT is almost like
synthetic bone in a syringe
so what you do is you inejct it where you have
a damage to your bone, and after
six to twelve months
CERAMENT our product has been completely replaced
by the patients own bone and you have complete healing
Basically
So what are the markets that you are currently adressing, is it mostly
the western countries, the US, Europe?
So we are a small company, so we are focusing on
the five biggest markets in Europe as well as the US
and we are targeting right now patients that have had trauma
so traffic accident is one of the biggest reasons to why you have insuficcient bone healing
as well as if there is bone infection
or if there are tumors for example in the skeleton
And if we were to look a bit at the numbers
what isthe market potential for your product and the markets that you are adressing
So in the market that we are looking at
There is 650 000 procedures every year
so surgeries to heal bones
and this market is worth about half a billion dollars, and fast growing about 5 to 6 percent a year
And if you look out of an investor perspective
moving forward, are there any specific events or news that we could be on the lookout for?
So we recently published our quarter two report
and very encouraging growth of close to 60 percent in Europe
and during this autumn you will see that we will supplement previous evidence with health economic data
and we will also publish a study which will show that
our product CERAMENT is as good as using
your own bone tissue for transplantation
So a synthetic product as good as the body's natural healing process
That sounds impressive
Thank you very much for being here today
and thank you for the walk through
Thank you so much
